Kazia Therapeutics Limited (KZIA) stock rallied over 1.14% intraday to trade at $1.78 a share on NASDAQ. The stock opened with a gain of 4.09% at $1.68 and touched an intraday high of $1.805, rising 2.30% against the last close of $1.74. The stock went to a low of $1.65 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Three International Towers
Level 24 300 Barangaroo Avenue
Sydney, NSW 2000
Sales or Revenue15.19 Million
5Y Sales Change106.5%
Fiscal Year Ends2021-06-29
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Kazia Therapeutics Limited (NASDAQ: KZIA) stock price is $1.78 as of the last check on Wednesday, August 17. During the trading session, KZIA stock reached the peak price of $1.805 while $1.65 was the lowest point it dropped to.
The NASDAQ listed KZIA is part of Biotechnology industry that operates in the broader Health Care sector. Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma.
Dr. James Garner M.A.I.C.D., M.B.A., B.Sc., M.A., MBA, MBBS, B.Sc (
CEO, MD & Exec. Director
Ms. Gabrielle Heaton BBUS (ACC), CPA
Director of Fin. & Admin.
Ms. Catherine Jane Hill ACA, B.Sc., BSc (Hons), C.A., GAICD
Ms. Karen R. Krumeich
Chief Financial Officer
KZIA stock traded closed the last session at $1.78, which is $0.020000000000000018 or 1.1363636363636374% lower than its previous close of $1.74. KZIA's current trading price is 10.56% lower than its 52-week high of $12.28 where as its distance from 52-week low of 1.61% is -85.5%.
Number of KZIA employees currently stands at -. KZIA operates from Three International Towers, Level 24 300 Barangaroo Avenue, Sydney, NSW 2000, Australia.
Official Webiste of $KZIA is: https://www.kaziatherapeutics.com
KZIA could be contacted at KZIA operates from Three International Towers, Level 24 300 Barangaroo Avenue, Sydney, NSW 2000, Australia, or at phone # and can also be accessed through its website.
KZIA stock volume for the day was 12,475 shares while in the previous session number of KZIA shares traded was 111,307 . The average number of KZIA shares traded daily for last 3 months was 634.46 Thousands.
The percentage change in KZIA stock occurred in the recent session was 1.1363636363636374% while the dollar amount for the price change in KZIA stock was $0.020000000000000018.
In the recent session, the day high for KZIA stock was $1.805 while the low for KZIA stock touched on the day was $1.65.
The market value of KZIA currently stands at 24.56 Million with its latest stock price at $1.78 and 13.2 Million of its shares outstanding.